ReWalk Robotics Ltd. (RWLK)


+0.01 (+0.82%)
Symbol RWLK
Price $0.735
Beta 2.478
Volume Avg. 0.22M
Market Cap 45.669M
Shares () -
52 Week Range 0.56-1.01
1y Target Est -
DCF Unlevered RWLK DCF ->
DCF Levered RWLK LDCF ->
ROE -29.65% Sell
ROA -29.99% Sell
Operating Margin -
Debt / Equity 1.96% Neutral
P/E -2.37 Sell
P/B 0.74 Buy


Consensus EPS

Upgrades & Downgrades

Latest RWLK news

Mr. Lawrence J. Jasinski BS, MBA
Medical Devices
NASDAQ Capital Market

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.